Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 09 2020
Historique:
received: 21 03 2019
accepted: 11 08 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 16 3 2021
Statut: epublish

Résumé

Shwachman-Diamond syndrome (SDS), an autosomal recessive disorder characterized by bone marrow failure, exocrine pancreatic insufficiency, and skeletal abnormalities, is caused by mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene, which plays a role in ribosome biogenesis. Although the causative genes of congenital disorders frequently involve regulation of embryogenesis, the role of the SBDS gene in early hematopoiesis remains unclear, primarily due to the lack of a suitable experimental model for this syndrome. In this study, we established induced pluripotent stem cells (iPSCs) from patients with SDS (SDS-iPSCs) and analyzed their in vitro hematopoietic and endothelial differentiation potentials. SDS-iPSCs generated hematopoietic and endothelial cells less efficiently than iPSCs derived from healthy donors, principally due to the apoptotic predisposition of KDR

Identifiants

pubmed: 32908229
doi: 10.1038/s41598-020-71844-8
pii: 10.1038/s41598-020-71844-8
pmc: PMC7481313
doi:

Substances chimiques

Proteins 0
SBDS protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14859

Commentaires et corrections

Type : ErratumIn

Références

Shwachman, H., Diamond, L., Oski, F. & Khaw, K. T. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J. Pediatr. 65, 645–663 (1964).
doi: 10.1016/S0022-3476(64)80150-5
Smith, O. P., Hann, I. M., Chessells, J. M., Reeves, B. R. & Milla, P. Haematological abnormalities in Shwachmann-Diamond syndrome. Br. J. Haematol. 94, 279–284 (1996).
doi: 10.1046/j.1365-2141.1996.d01-1788.x
Cesaro, R. et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br. J. Haematol. 131, 231–236 (2005).
doi: 10.1111/j.1365-2141.2005.05758.x
Boocock, G. R. B. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 33, 97–101 (2003).
doi: 10.1038/ng1062
Menne, T. F. et al. The Shwachman-Boidan-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 39, 486–495. https://doi.org/10.1038/ng1994 (2007).
doi: 10.1038/ng1994 pubmed: 17353896
Finch, A. J. et al. Uncoupling of GTP hydrolysis from elF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 25, 917–929. https://doi.org/10.1101/gad.623011 (2011).
doi: 10.1101/gad.623011 pubmed: 21536732 pmcid: 3084026
Weis, F. et al. Mechanism of elF6 release from the nascent 60S ribosomal subunit. Nat. Struct. Mol. Biol. 22, 914–919. https://doi.org/10.1038/nsmb.3112 (2015).
doi: 10.1038/nsmb.3112 pubmed: 26479198 pmcid: 4871238
Wessels, D. et al. The Shwachman-Bodian-Diamond syndrome gene encodes an RNA-binding protein that localizes to the pseudopod of Dictyostelium amoebae during chemotaxis. J. Cell Sci. 119, 370–379 (2006).
doi: 10.1242/jcs.02753
Austin, K. M. et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J. Clin. Invest. 118, 1511–1518. https://doi.org/10.1172/JCI33764 (2008).
doi: 10.1172/JCI33764 pubmed: 18324336 pmcid: 2263145
Rujkijyanont, P. et al. SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway. Haematologica 93, 363–371. https://doi.org/10.3324/haematol.11579 (2008).
doi: 10.3324/haematol.11579 pubmed: 18268284
Watanabe, K. et al. SBDS-deficiency results in specific hypersensitivity to Fas stimulation and accumulation of Fas at the plasma membrane. Apoptosis 14, 77–89. https://doi.org/10.1007/s10495-008-0275-9 (2009).
doi: 10.1007/s10495-008-0275-9 pubmed: 19009351
Ball, J. L. et al. Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses. Hum. Mol. Genet. 18, 3684–3695. https://doi.org/10.1093/hmg/ddp316 (2009).
doi: 10.1093/hmg/ddp316 pubmed: 19602484 pmcid: 2742402
Warren, A. J. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv. Biol. Regul. 67, 109–127. https://doi.org/10.1016/j.jbior.2017.09.002 (2018).
doi: 10.1016/j.jbior.2017.09.002 pubmed: 28942353 pmcid: 6710477
Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66 (1995).
doi: 10.1038/376062a0
Shalaby, F. et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981–990 (1997).
doi: 10.1016/S0092-8674(00)80283-4
Nishikawa, S. I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. & Kodama, H. Progressive lineage analysis by cell sorting and culture identifies FLK1+ VE-cadherin+ cells at diverging point of endothelial and hematopoietic lineages. Development 125, 1747–1757 (1998).
pubmed: 9521912
Wlison, N. K., Calero-Nieto, F. J., Ferreira, R. & Göttgens, B. Transcriptional regulation of haematopoietic transcription factors. Stem Cell Res. Ther. 2, 6. https://doi.org/10.1186/scrt47 (2011).
doi: 10.1186/scrt47
Narla, A. & Ebert, B. L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 115, 3196–3205. https://doi.org/10.1182/blood-2009-10-178129 (2010).
doi: 10.1182/blood-2009-10-178129 pubmed: 20194897 pmcid: 20194897
Tourlakis, M. E. et al. Deficiency of Sbds in the mouse pancreas leads to features of Shwachman-Diamond syndrome, with loss of zymogen granules. Gastroenterology 143, 481–492. https://doi.org/10.1053/j.gastro.2012.04.012 (2012).
doi: 10.1053/j.gastro.2012.04.012 pubmed: 22510201
Tourlakis, M. E. et al. In vivo senescence in the Sbds-deficient murine pancreas: cell-type specific consequences of translation in sufficiency. PLoS Genet. 11, e1005288. https://doi.org/10.1371/journal.pgen.1005288 (2015).
doi: 10.1371/journal.pgen.1005288 pubmed: 26057580 pmcid: 4461263
Zambetti, N. A. et al. Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes. Haematologica 100, 1285–1293. https://doi.org/10.3324/haematol.2015.131573 (2015).
doi: 10.3324/haematol.2015.131573 pubmed: 26185170 pmcid: 4591760
Zambetti, N. A. et al. Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia. Cell Stem Cell 19, 613–627. https://doi.org/10.1016/j.stem.2016.08.021 (2016).
doi: 10.1016/j.stem.2016.08.021 pubmed: 27666011
Zhang, S., Shi, M., Hui, C. C. & Rommens, J. M. Loss of the mouse ortholog of the Shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality. Mol. Cell Biol. 26, 6656–6663 (2006).
doi: 10.1128/MCB.00091-06
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
doi: 10.1016/j.cell.2007.11.019
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
doi: 10.1126/science.1151526
Niwa, A. et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS ONE 6, e22261. https://doi.org/10.1371/journal.pone.0022261 (2011).
doi: 10.1371/journal.pone.0022261 pubmed: 21818303 pmcid: 3144871
Morishima, T. et al. Neutrophil differentiation from human-induced pluripotent stem cells. J Cell Physiol 226, 1283–1291. https://doi.org/10.1002/jcp.22456 (2011).
doi: 10.1002/jcp.22456 pubmed: 20945397
Tanaka, T. et al. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood 120, 1299–1308. https://doi.org/10.1182/blood-2012-03-417881 (2012).
doi: 10.1182/blood-2012-03-417881 pubmed: 22723549
Morishima, T. et al. Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis. Haematologica 99, 19–27. https://doi.org/10.3324/haematol.2013.083873 (2014).
doi: 10.3324/haematol.2013.083873 pubmed: 23975175 pmcid: 4007926
Suzuki, N. M. et al. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors. Stem Cells Trans. Med. 4, 333–338. https://doi.org/10.5966/sctm.2013-0172 (2015).
doi: 10.5966/sctm.2013-0172
Okita, K. et al. An efficient nonviral method to generated integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458–466. https://doi.org/10.1002/stem.1293 (2013).
doi: 10.1002/stem.1293 pubmed: 23193063
Orelio, C. & Kuijpers, T. W. Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics. Haematologica 94, 409–413. https://doi.org/10.3324/haematol.13733 (2009).
doi: 10.3324/haematol.13733 pubmed: 19211642 pmcid: 2649349
Dror, Y. & Freedman, M. H. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood 97, 3011–3301 (2001).
doi: 10.1182/blood.V97.10.3011
Sieff, C. A. et al. Pathogenesis of the erythroid failure in Diamond Blackfan anaemia. Br. J. Haematol. 148, 611–622. https://doi.org/10.1111/j.1365-2141.2009.07993.x (2010).
doi: 10.1111/j.1365-2141.2009.07993.x pubmed: 19958353
Tulpule, A. et al. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell 12, 727–736. https://doi.org/10.1016/j.stem.2013.04.002 (2013).
doi: 10.1016/j.stem.2013.04.002 pubmed: 23602541 pmcid: 3755012
Donati, G., Montanaro, L. & Drerenzini, M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 72, 1602–1607. https://doi.org/10.1158/0008-5472.CAN-11-3992 (2009).
doi: 10.1158/0008-5472.CAN-11-3992
Shimamura, A. & Alter, B. P. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 24, 101–122. https://doi.org/10.1016/j.blre.2010.03.002 (2010).
doi: 10.1016/j.blre.2010.03.002 pubmed: 20417588 pmcid: 3733544
Austin, K. M., Leary, R. J. & Shimamura, A. The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood 106, 1253–1258 (2005).
doi: 10.1182/blood-2005-02-0807
Zhang, Y. et al. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs. Dev. Cell 24, 411–425. https://doi.org/10.1016/j.devcel.2013.01.018 (2013).
doi: 10.1016/j.devcel.2013.01.018 pubmed: 23449473 pmcid: 3586312
Wan, Y. et al. Transcriptome analysis reveal a ribosome constitutes disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia. BMC Med. Genomics 9, 13. https://doi.org/10.1186/s12920-016-0174-9 (2016).
doi: 10.1186/s12920-016-0174-9 pubmed: 26961822 pmcid: 4785739
Garçon, L. et al. Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 122, 912–921. https://doi.org/10.1182/blood-2013-01-478321 (2013).
doi: 10.1182/blood-2013-01-478321 pubmed: 23744582 pmcid: 3739037
Mccann, K. L. & Baserga, S. J. Genetics. Mysterious ribosomopathies. Science 341, 849–850. https://doi.org/10.1126/science.1244156 (2013).
doi: 10.1126/science.1244156 pubmed: 23970686 pmcid: 3893057
Shammas, C. et al. Structural and mutational analysis of the SBDS protein family. J. Biol. Chem. 280, 19221–19229 (2005).
doi: 10.1074/jbc.M414656200
Umeda, K. et al. Identification and characterization of hemoangiogenic progenitors during cynomolgus monkey embryonic stem cell differentiation. Stem Cells 24, 1348–1358 (2006).
doi: 10.1634/stemcells.2005-0165
Choi, K. D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559–567. https://doi.org/10.1634/stemcells.2008-0922 (2009).
doi: 10.1634/stemcells.2008-0922 pubmed: 19259936 pmcid: 2931800

Auteurs

Takayuki Hamabata (T)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Katsutsugu Umeda (K)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. umeume@kuhp.kyoto-u.ac.jp.

Kagehiro Kouzuki (K)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Takayuki Tanaka (T)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Tomoo Daifu (T)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Seishiro Nodomi (S)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Satoshi Saida (S)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Itaru Kato (I)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Shiro Baba (S)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Hidefumi Hiramatsu (H)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Mitsujiro Osawa (M)

Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Akira Niwa (A)

Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Megumu K Saito (MK)

Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Yasuhiko Kamikubo (Y)

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Souichi Adachi (S)

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Yoshiko Hashii (Y)

Department of Cancer Immunotherapy, Osaka University School of Medicine, Suita, 565-0871, Japan.

Akira Shimada (A)

Department of Pediatric Hematology/Oncology, Okayama University, Okayama, 700-8558, Japan.

Hiroyoshi Watanabe (H)

Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, 770-8501, Japan.

Kenji Osafune (K)

Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Keisuke Okita (K)

Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Tatsutoshi Nakahata (T)

Drug Discovery Technology Development Office, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.

Kenichiro Watanabe (K)

Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, 420-8660, Japan.

Junko Takita (J)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Toshio Heike (T)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH